Histologic subtyping of ampullary carcinoma for targeted therapy

참고문헌 (6)

1. Regalla DK, "Therapeutic options for ampullary carcinomas : a review", Oncol Rev, 13, pp.440~ (2019)
2. Niraj Kumari, "Identification of PI3K-AKT signaling as the dominant altered pathway in intestinal type ampullary cancers through whole-exome sequencing", Journal of Pathology and Translational Medicine, 55(3), pp.192~201 (2021), 대한병리학회[DOI]
3. Hechtman JF, "Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2(HER2)", Mod Pathol, 28, pp.1123~1129 (2015)
4. Gingras MC, "Ampullary cancers harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT dysregulation", Cell Rep, 14, pp.907~919 (2016)
5. Yachida S, "Genomic sequencing identifies ELF3 as a driver of ampullary carcinoma", Cancer Cell, 29, pp.229~240 (2016)
6. Kwon MJ, "Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value", Hum Pathol, 50, pp.90~100 (2016)

관련 논문AI추천